Kølendorf K, Jensen H A, Holst J J, Poulsen J E
Scand J Clin Lab Invest. 1982 Feb;42(1):69-74.
The hormonal and cardiovascular responses to intravenous (i.v.) insulin were studied in 16 insulin-dependent normotensive diabetic patients after acute injection of selective beta-1-adrenoceptor blocking agents. The lowest blood glucose levels were not affected by beta-1-adrenoceptor blockade while the time for reaching nadir was significantly reduced. Plasma adrenaline levels increased significantly during selective beta-1-adrenoceptor blockade. Plasma noradrenaline, glucagon and human growth hormone levels, however, remained unaffected. The insulin-induced tachycardia was not prevented by the beta-1-blockade, and the mean arterial blood pressure was unchanged. The ability to recognize the symptoms of insulin-induced hypoglycaemia persisted in all patients, although less pronounced in nine of them. We suggest that selective beta-1-adrenergic blocking agents may be employed without risk in the treatment of hypertensive insulin-dependent diabetic patients.
在16例胰岛素依赖型血压正常的糖尿病患者急性注射选择性β1肾上腺素能受体阻滞剂后,研究了静脉注射胰岛素时的激素和心血管反应。最低血糖水平不受β1肾上腺素能受体阻滞的影响,而达到最低点的时间显著缩短。在选择性β1肾上腺素能受体阻滞期间,血浆肾上腺素水平显著升高。然而,血浆去甲肾上腺素、胰高血糖素和人生长激素水平未受影响。β1阻滞剂不能预防胰岛素引起的心动过速,平均动脉血压也未改变。所有患者识别胰岛素引起低血糖症状的能力仍然存在,尽管其中9例患者这种能力不太明显。我们建议,在治疗高血压胰岛素依赖型糖尿病患者时,可无风险地使用选择性β1肾上腺素能阻滞剂。